SCA
RVMD icon

Sandy Cove Advisors’s Revolution Medicines RVMD Stock Holding History

Sandy Cove Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.06M Hold
27,008
– – 1.27% 21
2026
Q1 		$2.63M Hold
27,008
– – 0.79% 27
2025
Q4 		$2.15M Hold
27,008
– – 0.64% 28
2025
Q3 		$1.26M Hold
27,008
– – 0.4% 38
2025
Q2 		$994K Hold
27,008
– – 0.36% 45
2025
Q1 		$955K Sell
27,008
-15,000
-36% -$609K 0.38% 43
2024
Q4 		$1.84M Buy
+42,008
New +$2.12M 0.72% 24

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Sandy Cove Advisors's RVMD Position: Q2 2026 in Review

Sandy Cove Advisors held its Revolution Medicines (RVMD) position steady in Q2 2026 at 27,008 shares worth $5.06M. The position accounts for 1.27% of the portfolio, ranked #21.

Sandy Cove Advisors first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Sandy Cove Advisors held 27,008 shares of Revolution Medicines worth $5.06M as of Q2 2026.
  • Sandy Cove Advisors left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 1.27% of Sandy Cove Advisors's portfolio in Q2 2026, its #21 holding.
  • Sandy Cove Advisors first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Sandy Cove Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.